Cardiovascular Medicine and Haematology articles for University of Pennsylvania (Penn), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 80

Article ‘Count’ for Cardiovascular Medicine and Haematology.

Journal Count Share
1 0.30
Artificial intelligence-assisted multiscale lung modeling to predict alveolar septal wall stress 0.30
1 0.33
The effects of a smoking cessation intervention on mortality after a 32.5-year follow-up period: a randomized clinical trial 0.33
3 0.09
Idiopathic Pulmonary Fibrosis Risk Loci in East Asian Populations Mirror those of European Populations 0.02
CES1 Deficiency is Associated With Metabolic Reprograming and Endothelial Dysfunction in Pulmonary Arterial Hypertension 0.04
Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities. 0.03
1 0.06
Intraoperative Cardiac Events in Pediatric Patients with Congenital Heart Disease Undergoing Noncardiac Procedures: Analysis of a Large Multicenter Registry. 0.06
2 0.55
Proximal Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in the OSPREY Study : A Randomized Controlled Trial. 0.05
The Risk for Bleeding in Patients With Atrial Fibrillation From Concomitant Use of Apixaban or Rivaroxaban With Diltiazem Compared With Metoprolol. 0.50
1 0.06
<atl>Prospective, Multicenter Evaluation of Transcarotid Artery Revascularization in Standard‐Risk Patients: 30‐Day Outcomes of the scpROADSTER/scp 3 Study</atl> 0.06
1 0.05
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis 0.05
4 0.25
The Effect of Benralizumab and Mepolizumab on Use of Oral Glucocorticoids in Patients with Eosinophilic Granulomatosis with Polyangiitis 0.07
Performance of an Idiopathic Pulmonary Fibrosis Derived Multibiomarker Panel for Rheumatoid Arthritis‐Associated Interstitial Lung Disease 0.03
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis 0.13
Clinical manifestations of scpVEXAS/scp syndrome across a broad spectrum of scpUBA1/scp mutation burden 0.03
8 2.36
An optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing 0.55
A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study 0.03
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study 0.03
TNFα signaling restores steady-state hematopoiesis in a TNFαKO mouse model of anemia of inflammation 0.05
Modeling the HLH immune synapse uncovers critical roles for IS termination, cytokine intensity, and target cell death 0.41
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab 0.04
Rapid ADAMTS13 activity assays for thrombotic thrombocytopenic purpura: a systematic review and meta-analysis 0.93
Destabilization of PF4-antigenic complexes in heparin-induced thrombocytopenia 0.31
1 0.87
NAD-dependent redox control enables endothelial quiescence and vascular stabilization during angiogenesis 0.87
3 0.23
Three-Year Outcomes of Proximal Hypoglossal Nerve Stimulation in OSA 0.03
An inventory of clinical sarcoidosis status in the United States 0.06
Procedure Patterns and Survival in Advanced Non-Small Cell Lung Cancer with Malignant Airway Obstruction: A SEER-Medicare Analysis 0.14
9 2.30
The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis. 0.08
The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants. 0.03
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic Cardiomyopathy. 0.09
Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration. 0.03
Myocardial Recovery With Mechanical Circulatory Support Is Linked to Alternative Splicing and Subcellular Localization of CAMK2D. 0.09
OxLDL-Targeted Chimeric Antigen Receptor T Regulatory Cells Reduce Atherosclerotic Plaque Development. 0.96
Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy. 0.95
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial. 0.04
Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy. 0.03
1 0.14
Associations between antibiotic use and outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays 0.14
3 0.20
Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries 0.10
Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study 0.05
Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study 0.06
4 0.29
Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy: The FROSTBITE-2 Randomized Clinical Trial. 0.07
Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy 0.01
Real-World Outcomes of Transcatheter Tricuspid Valve Replacement 0.02
Impact of the MISSION Act on Quality and Outcomes of Major Cardiovascular Procedures Among Veterans 0.18
3 1.09
Divergent pathways of Surfactant Protein C maturation for disease-associated isoforms 0.51
S2Tag, a novel affinity tag for the capture and immobilization of coiled-coil proteins: Application to the study of human β-cardiac myosin 0.50
Identification and rescue of congenital hyperinsulinism-associated ABCC8 mutations that impair KATP channel trafficking 0.07
3 0.46
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma 0.09
ADAMTS7 promotes smooth muscle foam cell expansion in atherosclerosis 0.17
Allergen-specific mRNA–lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice 0.20
1 0.47
Unveiling sex dimorphism in the healthy cardiac anatomy: Fundamental differences between male and female heart shapes 0.47
4 0.39
Ten-year outcomes of valve-replacing versus valve-sparing aortic root replacement in Marfan syndrome patients: An observational multicenter study 0.08
Quality of life after mitral valve surgery: Results from the Cardiothoracic Surgical Trials Network 0.08
Contemporary outcomes and health care costs associated with single-ventricle heart failure admissions in adults in the United States 0.22
Computational fluid dynamics-based risk stratification of modified Blalock-Taussig-Thomas shunt thrombogenicity 0.01
10 1.15
Body Mass Index, Clinical Outcomes, and Mortality in Heart Failure: A Mendelian Randomization Study 0.09
Use of the Ross Procedure in North America 0.12
Natriuretic Peptide Receptor-1 Agonist for Resistant Hypertension A Randomized Phase 2 Trial 0.10
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US 0.01
Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT 0.09
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy Insights From the ODYSSEY-HCM Trial 0.04
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy Exploratory Insights From the ODYSSEY-HCM Trial 0.05
Prevalence and Predictors of Neurocognitive Dysfunction in Adults With Congenital Heart Disease Results From MINDS-ACHD 0.05
AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care Populations 0.18
Long-Term Survival and Patient-Reported Outcomes After Staged Reconstructive Surgery for Hypoplastic Left Heart Syndrome 0.43
1 0.25
Computational Characterization of Lymphocyte Topology on Whole Slide Images of Glomerular Diseases. 0.25
7 1.50
Depression of tryptophan may contribute to adverse effects of naproxen 0.88
Single cell spatial transcriptomics integration deciphers the morphological heterogeneity of atherosclerotic carotid arteries 0.06
Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies 0.13
Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese population 0.08
mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosis 0.15
Cross-population GWAS and proteomics improve risk prediction and reveal mechanisms in atrial fibrillation 0.19
Association between self-reported multimorbidity and longitudinal brain Aβ deposition in Alzheimer’s disease 0.00
1 0.00
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study 0.00
1 0.58
A myosin hypertrophic cardiomyopathy mutation disrupts the super-relaxed state and boosts contractility by enhanced actin attachment 0.58
1 0.08
CT Emphysema and Deep Learning-derived Vertebral Bone Loss in Individuals without COPD: Findings from MESA. 0.08
2 0.15
Severe obesity in human HFpEF alters contractile protein function and organization 0.10
Deep-learning analysis of 3D microarchitectural remodeling in hypertrophic cardiomyopathy 0.05
3 0.16
Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy 0.03
Transcatheter or Surgical Aortic-Valve Replacement in Low-Risk Patients at 7 Years 0.10
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy 0.04

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.